Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-10

Clinical Trial Update: Speech, Linguistic and Acoustic Markers in Parkinson's Disease

View source ↗

Summary

A completed study evaluated speech, linguistic, and acoustic markers in Parkinson disease with mild cognitive impairment; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Parkinson Disease, Cognitive Impairment, Mild | Status: COMPLETED | Results posted: 2025-06-10